Psychedelics Co. Pasithea Therapeutics Prices $24M IPO At $5 Per Share
September 15, 2021 at 21:30 PM EDT
Pasithea Therapeutics, a biotechnology company focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders, filed its registration statement on Form S-1 for a proposed $24.0 million IPO.